All‐cause mortality (30 days)—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—non‐cardiac surgery compared with control—non‐cardiac surgery (low certainty).
1 finding from 1 review
Mortality (within 30 days after surgery) · adult participants, irrespective of gender and type of non‐cardiac surgery, with mild or severe preoperative anaemia
rHuEPO with iron showed no clear difference in mortality (within 30 days after surgery) compared with control treatment with or without iron (moderate certainty).
1 finding from 1 review
All‐cause mortality (30 days)—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing non‐cardiac surgery
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in all‐cause mortality (within 30‐days after surgery: any reported death) compared with control (moderate certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing cardiac surgery
1 finding from 1 review
Cardiac mortality · adults undergoing non‐cardiac surgery
1 finding from 1 review
Mortality ‐ Death at any time after surgery · adult cardiac surgical patients
Low‐dose opioid‐based GA showed no clear difference in mortality ‐ Death at any time after surgery compared with high‐dose opioid‐based GA (low certainty).
1 finding from 1 review
Mortality ‐ Death at any time after surgery · adult cardiac surgical patients
Time‐directed extubation protocol showed no clear difference in mortality ‐ Death at any time after surgery compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · adults (aged > 16 years) without acute lung injury needing mechanical positive pressure ventilation during their surgery and undergoing…
Low tidal volume showed no clear difference in mortality compared with high tidal volume (low certainty).
1 finding from 1 review
All‐cause mortality · any people undergoing surgery with fluid resuscitation
1 finding from 1 review
Hospital mortality · adults (aged > 17 years) with acute respiratory failure after upper abdominal surgery
Noninvasive positive pressure ventilation (NPPV) showed no clear difference in hospital mortality compared with oxygen therapy (low certainty).
1 finding from 1 review
All‐cause mortality · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
Mortality (0 to 30 days) · adult cardiac surgical patients
Epidural analgesia showed no clear difference in mortality (0 to 30 days) compared with systemic analgesia (low certainty).
1 finding from 1 review
Mortality (0 to 30 days) · adults undergoing cardiac surgery without cardiopulmonary bypass
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mortality rate Risk ratio · cerebral protection during brain surgery
The intervention showed no clear difference in mortality rate Risk ratio (moderate certainty).
1 finding from 1 review
Mortality within the longest · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (at longest compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Mortality within the longest · adult surgical patients with the need for cardiopulmonary bypass‐dependent heart surgery
It is very uncertain whether pulmonary artery perfusion with blood changes all‐cause mortality within longest compared with no perfusion during cardiopulmonary bypass (very low certainty).
1 finding from 1 review
Mortality within the longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes all‐cause mortality (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
All‐cause mortality rate at 30 days · adults having abdominal surgery
Epidural analgesia showed no clear difference in all‐cause mortality rate at 30 days compared with intravenous patient‐controlled analgesia (low certainty).
1 finding from 1 review